Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.580, 2009-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Etanercept considered cost effective vs DMARDs in RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 446, 2004-01 ,pp. :
Access to resources
Recommend
Trastuzumab should be considered cost effective in France
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. :
Most public health interventions highly cost effective
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 644, 2012-01 ,pp. :
Eptifibatide cost-effective option for coronary interventions
Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. :
Child pneumonia interventions cost effective in reducing mortality
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 578, 2009-01 ,pp. :